Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
Ulrich Herrlinger(University of Tübingen), Martin Glas(Essen University Hospital), Dietmar Krex, Peter Vajkoczy(Humboldt-Universität zu Berlin), Stefanie Brehmer(Montreal Neurological Institute and Hospital), Bogdana Suchorska(Heidelberg University), Niklas Schäfer(University Hospital Bonn), Michael Weller(University Hospital of Zurich), Roland Goldbrunner(University of Cologne), Clemens Seidel(Leipzig University), Christina Schaub(University of Bonn), Hartmut Vatter(University Hospital Bonn), Matthias Simon(University of Bonn), Matthias Schmid(Zimmer Biomet (Netherlands)), Sied Kebir(University of Bonn), Rolf Fimmers(University of Bonn), Astrid Weyerbrock(University of Freiburg), Vera C. Keil(Amsterdam Neuroscience), Oliver Schnell(Friedrich-Alexander-Universität Erlangen-Nürnberg), Michael Nelles(University Hospital Bonn), Peter Hau(University Hospital Regensburg), Oliver Bähr(Antea Group (France)), Lars Bullinger(Stanford University), Oliver Grauer(University Hospital Münster), Martin Misch(Humboldt-Universität zu Berlin), Norbert Galldiks(Forschungszentrum Jülich), Theophilos Tzaridis(Sanford Burnham Prebys Medical Discovery Institute), Friederike Schmidt‐Graf(TUM Klinikum), Rolf‐Dieter Kortmann(University of Turin), Uwe Schlegel(Defence Research and Development Organisation), Moritz Stuplich(University of Bonn), Walter Stummer(University of Münster), Miriam Renovanz(Johannes Gutenberg University Mainz), Christoph Coch(University of Bonn), Elke Hattingen(Goethe University Frankfurt), Johannes Weller(University Hospital Bonn), Joachim P. Steinbach(Goethe University Frankfurt), Florian Ringel(Johannes Gutenberg University Mainz), Michael Sabel(Düsseldorf University Hospital), Wolfgang Wick(German Cancer Research Center), Martin Coenen(University Hospital Bonn), Ghazaleh Tabatabai(Goethe University Frankfurt), Frederic Mack(University of Bonn), Torsten Pietsch, Thomas E. Kowalski(Thomas Jefferson University), Martin Uhl(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jörg‐Christian Tonn(Goethe University Frankfurt), Horst Urbach(University of Freiburg)
Cited by 581
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k